Activist Investor 13D, 13G Filings
This page shows a list of all the recent 13D/G filings made by Satter Muneer A . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).
When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase.
|2017‑07‑14||AKBA / Akebia Therapeutics, Inc.||*||2,007,560||3,054,542||52.15||6.48||24.62|
|2017‑05‑30||ALBO / Albireo Pharma, Inc.||*||830,000||9.77|
|2017‑04‑25||EDGE / Edge Therapeutics, Inc.||*||1,800,000||5.8|
|2017‑04‑04||VTL / Vital Therapies, Inc.||*||7,254,449||11,034,688||52.11||26.9||19.56|
|2017‑02‑13||TKAI / Tokai Pharmaceuticals, Inc.||*||1,775,188||0||-100.00||0.0||-100.00|
|2017‑02‑13||VTL / Vital Therapies, Inc.||*||7,258,926||7,254,449||-0.06||22.5||-5.30|
|2017‑02‑13||AKBA / Akebia Therapeutics, Inc.||*||2,002,560||2,007,560||0.25||5.2||-2.62|
|2016‑02‑12||VTL / Vital Therapies, Inc.||*||7,258,926||23.76|
|2016‑02‑12||TKAI / Tokai Pharmaceuticals, Inc.||*||1,775,188||7.86|
|2016‑02‑12||AKBA / Akebia Therapeutics, Inc.||*||2,002,560||5.34|
Fintel IR - Find the Right Investors for Your Company, Instantly!Fintel IR combines the comprehensive Fintel ownership database with machine learning to provide advanced tools to make investor outreach fast and easy. Learn more now!
Join our private investing channel!Request Membership